Faculty: Faculty of Health and Life Sciences, Institute of Population Health, Department of Health Sciences. This one-year Master of Science program provides an advanced understanding of the biological mechanisms underlying cancer and the principles of cancer therapy. It typically covers areas such as molecular oncology, cancer genetics, tumour microenvironment, drug discovery and development, radiotherapy, immunotherapy, and translational research, preparing graduates for careers in cancer research and the development of new cancer treatments. The program is offered within the Department of Health Sciences, part of the Institute of Population Health in the Faculty of Health and Life Sciences, indicating a strong link to both fundamental science and clinical application.

Career options in cancer research (academia, industry), clinical research, pharmaceutical and biotechnology companies specializing in oncology, science writing, research management, and potentially further study at the PhD level. The University of Liverpool offers research-intensive learning and excellent graduate prospects in these fields.

The University of Liverpool is a member of the UK's prestigious Russell Group, known for its research-intensive universities and high academic standards, particularly strong in health and life sciences. As one of the six original red brick universities, it has a long-standing reputation for academic excellence. The university offers research-intensive learning, providing students with opportunities to engage with cutting-edge research, and boasts excellent graduate prospects in the biomedical and pharmaceutical sectors.